Stay updated on Subjects Metastatic Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Subjects Metastatic Solid Tumors Clinical Trial page.

Latest updates to the Subjects Metastatic Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedA new revision tag, Revision: v3.6.6, was added to the history. The previous tag, Revision: v3.6.5, was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a new study entry titled 'A Study of Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)' with a 2026-08-11 update indicating Results Posted and related sections (Outcome Measures (Results), Outcome Measures, Study Status). Removed the older cervical study entry 'Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)' (Results Submitted) dated 2023-07-05 from the history.SummaryDifference0.6%

- Check26 days agoChange DetectedThe record history now shows a new revision entry v3.6.5 and removes v3.6.4, indicating an update to the page's version history in the Study Record. This reflects ongoing maintenance of the study record's provenance and metadata.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page history now shows a new software revision, v3.6.4, indicating a recent update to the page. The previous revision, v3.6.3, is no longer present in the history.SummaryDifference0.1%

- Check62 days agoChange DetectedThe history now shows a new revision entry v3.6.3, replacing the previous v3.6.2 entry and indicating the page has been updated. This keeps the version history current.SummaryDifference0.1%

- Check69 days agoChange DetectedNew revision v3.6.2 appears in the history (dated 2026-05-29) and the earlier revision v3.6.0 is removed. The page now reflects additional record sections and status indicators (Returned date 2026-06-24, QC status Has Not Concluded, and sections like Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, and Study Status) indicating ongoing updates to the study record.SummaryDifference2%

Stay in the know with updates to Subjects Metastatic Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subjects Metastatic Solid Tumors Clinical Trial page.